Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.
A Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects
Subjects voluntarily participate in the study, sign the informed consent form, a... [+3]
Subjects with a known allergy to Tecovirimat drugs, any excipient ingredients in... [+22]